Literature DB >> 5643296

Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.

K N Drummond, D A Hillman, J H Marchessault, W Feldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5643296      PMCID： PMC1923912     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  15 in total

1.  Use of combined hormone and mechlorethamine (nitrogen mustard) therapy in lipoid nephrosis.

Authors:  C D WEST
Journal:  AMA J Dis Child       Date:  1958-05

2.  Immunosuppressive therapy. The relation between clinical response and immunologic competence.

Authors:  M A Swanson; R S Schwartz
Journal:  N Engl J Med       Date:  1967-07-27       Impact factor: 91.245

3.  The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations.

Authors:  K N Drummond; A F Michael; R A Good; R L Vernier
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

4.  Immunosuppressive therapy of chronic renal disease.

Authors:  A F Michael; R L Vernier; K N Drummond; J I Levitt; R C Herdman; A J Fish; R A Good
Journal:  N Engl J Med       Date:  1967-04-13       Impact factor: 91.245

5.  Successful therapy of trimethadione nephrosis with prednisone and cyclophosphamide. Report of a case.

Authors:  J D Northway; C D West
Journal:  J Pediatr       Date:  1967-08       Impact factor: 4.406

6.  Mercaptopurine in the treatment of steroid-resistant nephrotic syndrome.

Authors:  M A Shearn
Journal:  N Engl J Med       Date:  1965-10-28       Impact factor: 91.245

7.  Cyclophosphamide in the treatment of idiopathic lipoid nephrosis.

Authors:  J N Etteldorf; S Roy; R L Summitt; M J Sweeney; H P Wall; W M Berton
Journal:  J Pediatr       Date:  1967-05       Impact factor: 4.406

8.  Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.

Authors:  R H White; J S Cameron; J R Trounce
Journal:  Br Med J       Date:  1966-10-08

9.  Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children.

Authors:  W E Grupe; W Heymann
Journal:  Am J Dis Child       Date:  1966-11

10.  Azathioprine treatment of immunological renal disease.

Authors:  D A Adams; A Gordon; M H Maxwell
Journal:  JAMA       Date:  1967-02-13       Impact factor: 56.272
View more
  4 in total

1.  The morphological and clinical course of the different forms of glomerulonephritis.

Authors:  H Fishbach; A Bohle; D Meyer; H H Edel; U Frotscher; R Kluthe; D Renner; K Rinsche; F Scheler
Journal:  Klin Wochenschr       Date:  1976-02-01

2.  Gamma-globulin and complement in the pyelonephritic kidney.

Authors:  I Marosvári; E Beregi; K Szepesházi; H Román
Journal:  Int Urol Nephrol       Date:  1971       Impact factor: 2.370

3.  Cyclophosphamide therapy of idiopathic nephrosis.

Authors:  C M Grushkin; R N Fine; E Heuser; E Lieberman
Journal:  Calif Med       Date:  1970-12

4.  Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome.

Authors:  Viktória Sümegi; Ibolya Haszon; Csaba Bereczki; Ferenc Papp; Sándor Túri
Journal:  Pediatr Nephrol       Date:  2008-03-07       Impact factor: 3.714
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.